Private Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-11,100
Closed -$210K 137
2017
Q4
$210K Sell
11,100
-21,375
-66% -$404K 0.03% 133
2017
Q3
$572K Sell
32,475
-144,545
-82% -$2.55M 0.09% 94
2017
Q2
$5.88M Buy
177,020
+53,945
+44% +$1.79M 0.95% 40
2017
Q1
$3.95M Buy
123,075
+9,727
+9% +$312K 0.64% 46
2016
Q4
$4.11M Buy
113,348
+2,090
+2% +$75.8K 0.69% 46
2016
Q3
$5.12M Buy
111,258
+670
+0.6% +$30.8K 0.86% 39
2016
Q2
$5.56M Buy
110,588
+40,850
+59% +$2.05M 0.98% 37
2016
Q1
$3.73M Sell
69,738
-4,050
-5% -$217K 0.68% 47
2015
Q4
$4.84M Sell
73,788
-5,425
-7% -$356K 0.88% 38
2015
Q3
$4.47M Sell
79,213
-61,045
-44% -$3.45M 0.84% 38
2015
Q2
$8.29M Sell
140,258
-31,300
-18% -$1.85M 1.39% 24
2015
Q1
$10.7M Sell
171,558
-4,585
-3% -$286K 1.74% 19
2014
Q4
$10.1M Sell
176,143
-3,719
-2% -$214K 1.61% 22
2014
Q3
$9.67M Sell
179,862
-1,452
-0.8% -$78K 1.55% 21
2014
Q2
$9.5M Sell
181,314
-11,448
-6% -$600K 1.53% 21
2014
Q1
$10.2M Sell
192,762
-395
-0.2% -$20.9K 1.72% 16
2013
Q4
$7.74M Buy
193,157
+15,895
+9% +$637K 1.33% 25
2013
Q3
$6.7M Sell
177,262
-40,767
-19% -$1.54M 1.28% 26
2013
Q2
$8.55M Buy
+218,029
New +$8.55M 1.63% 17